SIM
CBIO

Spark Investment Management’s Crescent Biopharma CBIO Stock Holding History

Spark Investment Management’s Portfolio CBIO Stock Details CBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-245
Closed -$91K – 64
2020
Q2 		$91K Sell
245
-130
-35% -$36.8K 0.33% 51
2020
Q1 		$85K Buy
375
+188
+101% +$71.9K 0.05% 289
2019
Q4 		$98K Buy
+187
New +$101K 0.01% 498
2016
Q3 		– Sell
-114
Closed -$82K – 847
2016
Q2 		$82K Sell
114
-109
-49% -$75.1K 0.01% 719
2016
Q1 		$132K Sell
223
-240
-52% -$123K 0.01% 668
2015
Q4 		$264K Sell
463
-85
-16% -$56.3K 0.03% 514
2015
Q3 		$306K Sell
548
-61
-10% -$44K 0.04% 457
2015
Q2 		$473K Sell
609
-157
-20% -$130K 0.07% 370
2015
Q1 		$636K Buy
766
+135
+21% +$105K 0.09% 320
2014
Q4 		$453K Buy
631
+433
+219% +$339K 0.08% 339
2014
Q3 		$136K Buy
+198
New +$160K 0.02% 559

Other funds holding CBIO

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return